Pinku Mukherjee - Concepedia

Author

Pinku Mukherjee

University of North Carolina at Charlotte ORCID

Also Known As

Ogle, Craig A, P K Mukherjee, P MUKHERJEE, P Mukherjee, P. Mukherjee, PINKU MUKHERJEE, Pinku Mukherjee, Prabhat Mukherjee, Ross, Alana

194

Publications

8.5K

Citations

H-Index

114

Concepts

All Affiliations

University of North Carolina at Charlotte Mayo Clinic in Arizona Mayo Clinic Indiana University – Purdue University Indianapolis Carolinas Medical Center

About

Pinku Mukherjee is an author at University of North Carolina at Charlotte specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	39	3.1K
2	Engineering	5	5	288
3	Health Sciences	3	3	317
4	Natural Sciences	1	1	22
5	Applied Physiology	1	1	25

Pinku Mukherjee

Publications

Citations

H-Index

Page 1

	Year	Citations
Characterization of Definitive Lymphohematopoietic Stem Cells in the Day 9 Murine Yolk Sac Mervin C. Yöder, Kelly Hiatt, Parmesh Dutt, Immunity Developmental BiologyLymphocyte DevelopmentMedicineAdult Stem CellLymphatic System	1997	422
MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition Lopamudra Das Roy, Mahnaz Sahraei, Durai B. Subramani, Oncogene Tumor BiologyOncologyPancreatic CancerMedicinePancreatic Cancer Cells	2010	265
<i>In vivo</i>repopulating hematopoietic stem cells are present in the murine yolk sac at day 9.0 postcoitus Mervin C. Yöder, Kelly Hiatt, Pinku Mukherjee Proceedings of the National Academy of Sciences	1997	245
Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer Roheena Z. Panni, Dominic E. Sanford, Brian A. Belt, Cancer Immunology Immunotherapy	2014	216
CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth Ru Zhou, Mahboubeh Yazdanifar, Lopamudra Das Roy, Frontiers in Immunology T Cell TherapyBreast OncologyImmunologyImmunoeditingImmunodominance	2019	181
Prolactin Induction of Interleukin-2 Receptors on Rat Splenic Lymphocytes* Pinku Mukherjee, Andrea M. Mastro, W. C. Hymer Endocrinology	1990	179
MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes Sritama Nath, K. Daneshvar, Lopamudra Das Roy, Oncogenesis Tumor BiologyPancreatic CancerHealth SciencesOncogenic AgentMedicine	2013	174
Reduced T-Cell and Dendritic Cell Function Is Related to Cyclooxygenase-2 Overexpression and Prostaglandin E2 Secretion in Patients With Breast Cancer Barbara A. Pockaj, Gargi D. Basu, Latha Pathangey, Annals of Surgical Oncology Prostaglandin E2 SecretionBreast OncologyCancer ImmunosurveillanceImmunologyDendritic Cell Function	2004	168
Cyclooxygenase-2 Inhibitor Induces Apoptosis in Breast Cancer Cells in an <i>In vivo</i> Model of Spontaneous Metastatic Breast Cancer Gargi D. Basu, Latha Pathangey, Teresa L. Tinder, Molecular Cancer Research Breast OncologyApoptosisImmunologyCell DeathPathology	2004	151
Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells Gargi D. Basu, Latha Pathangey, Teresa L. Tinder, Breast Cancer Research	2005	140

Page 1